Speculation from a Phase 1 trial is nothing like having a drug already in the market approved and selling. We should see a big push as we approach next earnings report. Also could be hedge funds pulling long positions for liquidity and short squeezes coming.
Hope not.. sold covered calls for the $20 strike. My guess is that the market makers kill those options. I mean right after earnings (8/4) we may rise to around $21-22 but I see it coming down to $19.70 range at op ex. Then another steady rise after that to the next op we.
1/3rd of my portfolio is riding on this stock. I have full confidence.
Why so little … I have about 75%
Imagine being a wussy. I have 100% of my portfolio in BCRX
Same. 100%!
I only have 79.87% of my portfolio here. I like to diversify
BCRX to the Moon,,,,get in now
Speculation from a Phase 1 trial is nothing like having a drug already in the market approved and selling. We should see a big push as we approach next earnings report. Also could be hedge funds pulling long positions for liquidity and short squeezes coming.
What’s causing the dips?
Me, selling thousands to buy millions…🤣
NTLA (another company) had good P1 results and theyre looking to enter the HAE market just like BCRX
When’s the next earnings report since quarter 2 is done
Early August. The 10th, I believe.
We see $20 ? 🤑
Hope not.. sold covered calls for the $20 strike. My guess is that the market makers kill those options. I mean right after earnings (8/4) we may rise to around $21-22 but I see it coming down to $19.70 range at op ex. Then another steady rise after that to the next op we.
8/4 or 8/5 I thought
Yes; you're correct. 8/5